EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Complex Collision Tumors: A Systematic Review

Dua Abuquteish, Mohammad A. Al-Qudah

Judi Clinical Journal · 2025

DOI: 10.70955/jcj.2025.13 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Judi Clinical Journal, 2025. Verfasst von Dua Abuquteish und 1 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing. These rare tumors are usually identified incidentally in surgical specimens. This study systematically reviews complex collision tumors (those with three or more distinct histological types) to explore their features and clinical behavior.

Methods

A comprehensive literature search was conducted using Google Scholar, Consensus AI, and Perplexity AI to identify all articles that describe collision tumors comprising more than two distinct pathologies. Studies lacking full texts, reviews, or those from predatory journals were excluded. Data extracted included publication details, patient demographics, clinical and diagnostic findings, tumor characteristics, treatments, outcomes, and follow-up. Findings were analyzed qualitatively and summarized using frequencies, percentages, and means with standard deviations.

Results

A total of 2,798 articles were identified, and 26 studies (28 cases) met the inclusion criteria. Female patients accounted for 17 cases (60.72%), with a mean age of 63.46 ± 14.00 years. Surgery was performed in 26 cases (92.86%). Triple collision tumors were reported in 26 cases (92.86%), and quadruple collision tumors in 2 cases (7.14%). The thyroid gland was affected in 7 cases (25.00%), and papillary thyroid carcinoma was identified in 9 cases (32.14%). At the last follow-up, 22 patients (78.57%) were alive.

Conclusion

Complex collision tumors represent rare and histologically diverse entities with significant diagnostic and therapeutic implications. They are most frequently found in the thyroid and skin. Accurate diagnosis typically requires comprehensive histopathological and immunohistochemical analysis of the entire lesion.

Introduction

A collision tumor is defined by the presence of two histologically distinct neoplastic components situated adjacent to each other within the same organ. These components are separated by intervening stromal tissue and lack histological intermingling, thereby classifying the tumor as a type of multiple synchronous neoplasm [1]. The concept of collision tumors was first introduced by Bernet in 1902 and later refined by Meyer in 1919 [2]. They most commonly arise in the liver, stomach, adrenal glands, ovaries, lungs, kidneys, and colon [3]. Collision tumors are exceedingly rare and are typically discovered incidentally during the pathological examination of surgically resected specimens. Due to their rarity, the biological behavior and optimal treatment strategies for collision tumors remain poorly understood, with most available evidence limited to case reports and small case series [4]. From a histopathological viewpoint, collision tumors typically contain both epithelial and mesenchymal components. Therefore, they must be carefully differentiated from other biphasic neoplasms such as carcinosarcomas, which show squamous epithelial and spindle cell elements; composite tumors, which display mixed histologic patterns within one lesion; and tumor-to-tumor metastasis [5]. The exact mechanisms underlying the development of collision tumors remain poorly understood. These neoplasms are thought to originate from a common malignant progenitor cell, which subsequently differentiates into two distinct lineages, each retaining its own malignant characteristics [5]. Collision tumors can consist of different combinations, including two benign neoplasms, a benign and a malignant tumor, or two malignant tumors [6]. A defining feature is that each component preserves its own morphological, immunohistochemical, and sometimes genetic identity, despite its close anatomical proximity [7]. This study aims to systematically review complex collision tumors (defined here as neoplasms composed of three or more distinct histological types within a single anatomical site without any intermixing) and offer comprehensive insights into their characteristics and clinical behavior.

Methods

Study Design This systematic review was conducted following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Data Sources and Search Strategy A comprehensive literature search was conducted using Google Scholar, Consensus AI (Pro), and Perplexity AI to identify all articles that describe collision tumors comprising more than two distinct pathologies. In Google Scholar, the search strategy incorporated the use of the “allintitle” and “excluding citation” features. Each of the following terms: Collision, Triple, Quadruple, Triad, Colliding, Combined, Simultaneous, Coexisting, Coexistence, Multicomponent, and Concurrent was individually paired with pathology-related terms using Boolean operators: Tumor, Tumors, Tumour, Tumours, Malignancy, Malignancies, Neoplasm, Neoplasms, Cancer, Cancers, Histology, Histologies, Carcinoma, and Carcinomas. The search was restricted to English-language publications. In Consensus AI and Perplexity AI, searches were performed using natural language queries formulated in a systematic review format (e.g., “reports of collision tumors involving three or more histologically distinct malignancies”). Retrieved responses were screened for primary literature sources, with cross-verification through direct journal links to ensure inclusion of peer-reviewed articles only. Eligibility Criteria All studies or case reports describing collision tumors involving more than two distinct pathological components were considered eligible for inclusion. Exclusion criteria included inaccessible full texts, review articles, or publications appearing in journals with insufficient peer review standards. The authenticity of the included studies was confirmed by comparing their publishing journals against recognized lists of predatory journals [8]. Study Selection and Data Extraction Titles and abstracts were screened to remove studies of dual-component collision tumors, non-human publications, and irrelevant study designs, such as review articles and studies that did not align with the research objectives. Full-text articles that passed the initial screening were then reviewed in detail, with exclusions made for irrelevant studies. Data extracted from the eligible studies included: the first author’s name, year of publication, patient demographics, clinical presentations, affected organs, initial diagnostic methods, imaging findings, type of surgery performed, histological diagnosis, histopathological features, immunohistochemical markers, lymph node involvement, organ metastasis, adjuvant therapies, postoperative complications, follow-up duration, recurrence, and patient status at the last follow-up. Statistical Analyses The data were compiled using Microsoft Excel (version 2021) and analyzed qualitatively with the Statistical Package for the Social Sciences (SPSS, version 27.0). Results were presented as frequencies with corresponding percentages, and means with standard deviations.

Results

Study Identification A total of 2,798 articles were identified through the comprehensive search. After the initial screening, 616 articles were excluded for the following reasons: duplication (n = 359), non-English language (n = 104), unretrieved data (n = 77), abstract-only publications (n = 58), non-article formats (n = 10), and preprints (n = 8). The titles and abstracts of the remaining 2,182 articles were screened, and 2,145 were excluded due to irrelevance (n = 1,187), including dual-component collision tumors (n = 892), non-human studies (n = 19), review articles (n = 16), and publications in journals with inadequate peer review standards (n = 31). The remaining 37 articles underwent full-text screening, 11 of which were excluded due to lack of relevance. Consequently, 26 eligible articles, encompassing 28 cases of complex collision tumors, were included in the review [1, 5, 9-32] (Table 1). The steps taken to identify relevant studies are represented in the PRISMA diagram (Figure 1). Table 1. Demographics, Clinical Features, and Imaging Findings of the Included Cases Author (yr) Study design Age (yr)/Sex Country of origin Cause of presentation Duration Medical history Surgical history Family history of cancer History of radiation exposure Site of tumors Initial diagnostic method Imaging findings Luo et al., 2024 [5] Case report 58/M China Progressive dysphagia 2 Months None N/A None N/A Esophagus Barium swallow + gastroscopic biopsy Barium: Irregular filling defect 8.9×5.0 cm mid-esophagus. CT: Emphysema, bullae, mass. Gastroscopy: Mass 28-32 cm from incisors, blocks ⅔ of the lumen. Bahbahani et al., 2023 [9] Case report 57/M Kuwait Routine checkup N/A Hypertension, dyslipidemia, GERD None Thyroid, breast N/A Left kidney Urinalysis, US, Contrast CT, PET/CT US: multiple left renal cysts; CT: multiple complex cystic lesions (Bosniak III & IV); PET/CT: hypermetabolic lesions in the left kidney. Boukhannous et al., 2022 [10] Case report 59/M Morocco Febrile right flank pain Not specified Type 2 diabetes, hypertension N/A N/A N/A Right kidney CT, MRI, ultrasound-guided biopsy CT: Right renal abscess, bilateral septic emboli. MRI: Right renal lesion (8.1×7.8×8.2 cm), possible infection vs. tumor. Rose et al., 2021 [11] Case report 82/M United Kingdom Ulcerated keratotic lesion on the upper right ear 3 months Hypertension, multiple non-melanoma skin cancers N/A N/A N/A Right ear Clinical examination, excisional biopsy CT: no evidence of distant metastasis Rupchandani et al., 2021 [12] Case report 89/M United Kingdom Right forearm lesion N/A Osteoarthritis, glaucoma, Klinefelter syndrome, DVT, paroxysmal atrial fibrillation, SCC, and actinic keratoses Previous excisions for SCCs and actinic keratoses; wide local excisions for the current lesion N/A N/A Right forearm skin Clinical evaluation, excisional biopsy CT: local extension to axilla, right subpectoral and axillary lymphadenopathy, chest wall extension; no distant visceral metastasis Toyoshima et al., 2021 [13] Case report 63/F Brazil Longstanding thyroid nodules, neck pain, and dysphagia 25 years Chronic lymphocytic thyroiditis, Hashimoto’s thyroiditis Total thyroidectomy N/A N/A Thyroid gland US, FNA US: heterogeneous nodules with calcifications in the left thyroid lobe (largest 6.4 cm) Hobbs et al., 2020 [14] Case report 66/M United States Asymptomatic enlarging lesion on the right anterior shoulder 1 year End-stage renal disease (post-kidney transplant), cirrhosis (post-liver transplant), immunosuppression, multiple NMSCs Kidney and liver transplant N/A N/A Right anterior shoulder skin Biopsy CT chest/abdomen/pelvis: no metastatic disease detected Lai et al., 2020 [15] Case report 62/F Taiwan Epigastric pain and dysphagia Not specified N/A N/A N/A N/A Esophagus Upper GI endoscopy with biopsy CT: esophageal mass at mid-third esophagus (T2N0M0); PET: no distant metastasis; endoscopic US: T1N0. Mizoguchi et al., 2020 [16] Case report 63/F Japan Recurrent abnormal uterine bleeding and anemia N/A Diabetes mellitus, hypertension Appendectomy N/A N/A Uterus Hysteroscopy, pelvic exam, MRI, CT MRI: 3.4 cm multiple nodular mass confined to the uterine cavity, no myometrial invasion; CT: confined to the uterus, no lymphadenopathy or metastases. Roshini et al., 2018 [17] Case report 27/F India Right-sided neck swelling 1 year None N/A None None Thyroid gland Ultrasound + FNA US: 3.8×2.4 cm hypoechoic solid nodule with small cystic areas in the right lower thyroid lobe; left lobe and isthmus normal. Liu et al., 2017 [18] Case report 58/F United States Fevers, chills, abdominal fullness, chest/back pain 1 month Invasive ductal carcinoma of left breast Lumpectomy for breast cancer N/A Post-lumpectomy radiation therapy Right adrenal gland CT scan of the abdomen CT: 6.2×4.3 ×5.1 cm heterogeneous right adrenal mass, increased in size compared to prior imaging (3.2 cm in 2005); irregular enhancement. Schizas et al., 2017 [19] Case report 76/M Greece Progressive dysphagia, weight loss (15 kg over 4 months) 4 months GERD N/A N/A N/A Esophagus Upper GI endoscopy, biopsy, CT scan Endoscopy: Barrett’s esophagus, 2 nodules (mid-esophagus and cardia); CT: diffuse esophageal wall thickening; no lymphadenopathy or distant metastasis. Masuyama et al., 2016 [20] Case report 52/F Japan Genital bleeding N/A N/A N/A None N/A Uterus Transvaginal US, MRI, PET-CT, biopsy Transvaginal US: 4.9×4.9×5.7 cm mixed echogenic cervical mass; MRI: 5.5×5.1×5.2 cm hyperintense mass invading lower uterine segment; PET-CT: high FDG uptake in cervical and endometrial masses, no distant metastasis. Bloom et al., 2014 [21] Case report 68/F United States Large, red-brown plaque on left buttock Since childhood Hypertension, hyperlipidemia, non-alcoholic steatohepatitis Cholecystectomy None N/A Left buttock skin Clinical examination, shave biopsy N/A Kim et al., 2014 [22] Case report 67/F South Korea A palpable mass on the anterior neck 2 years None None None None Thyroid gland FNA US: right thyroid 4.4 cm heterogeneous iso-echoic nodule; left thyroid 1.2 cm low-echoic nodule; no cervical lymphadenopathy; no distinct features of papillary carcinoma on imaging. Suzuki et al., 2014 [23] Case report 72/M Japan Routine checkup N/A Lung disease None None N/A Lung Chest CT, PET-CT, transthoracic needle biopsy CT: infiltrative shadow in right lower lobe with air bronchogram; PET-CT: SUV max 2.6; no lymphadenopathy or distant metastasis. Adnan et al., 2013 [24] Case series 43/F Israel Thyroid follicular nodular disease N/A N/A N/A None N/A Thyroid gland FNA N/A 44/F Israel Thyroid nodule N/A N/A N/A None N/A Thyroid gland FNA N/A 77/F Israel Incidental thyroid nodule N/A Osteoporosis N/A None None Thyroid gland FNA CT: right thyroid nodule 1.63 cm; US: solid, hypervascular nodule. Cornejo et al., 2013 [25] Case report 84/M United States Pearly, nonpigmented papule on the chest Not specified Multiple actinic keratoses, basal cell carcinoma N/A N/A N/A Chest skin Shave biopsy N/A Jang et al., 2012 [1] Case report 70/F South Korea Abnormal uterine bleeding and abdominal pain N/A Hypertension N/A None N/A Uterus Transvaginal US, pelvic CT Transvaginal US: 9.2×5.9 cm mixed echogenic mass; CT: Large endometrial mass with myometrial invasion, omental nodules; MRI: Heterogeneous uterine mass with poor enhancement, peritumoral infiltration. Rothschild et al., 2010 [26] Case report 74/F United States Left flank pain Not specified Long history of recurrent UTIs and renal calculi N/A N/A N/A Left kidney US, CT with contrast, MAG3 renal scan US: enlarged left kidney with cystic areas and stones; CT: staghorn calculus, multiple cystic low-attenuation lesions replacing parenchyma, consistent with XGP; MAG3 scan: non-functioning left kidney. Terada, 2010 [27] Case report 66/F Japan Cough; lung shadow detected on chest X-ray N/A N/A N/A N/A N/A Lung Chest X-ray, CT, MRI, lung biopsy Chest X-ray: abnormal shadow; CT/MRI: 3.5 cm mass in the right lower lobe, multiple lung metastases. Broughton et al., 2008 [28] Case report 78/F Belgium Fever, painful left axillary swelling, nausea, loss of appetite, asthenia 2 weeks Hypothyroidism, psoriasis, Diabetes mellitus Hysterectomy, left breast tumor resection N/A N/A Left axillary lymph nodes FNA CT: left axillary lymphadenopathy with surrounding soft tissue inflammation; PET: hot spots in the left axillary region, left breast, spleen, gastric fundus, left infraclavicular region. Wang et al., 2008 [29] Case report 62/M United States Vocal fatigue; nasopharyngeal mass N/A None N/A N/A N/A Nasopharynx Videolaryngoscopy, biopsy, IHC, flow cytometry CT neck, chest, abdomen, pelvis: negative for additional disease. Rekhi et al., 2007 [30] Case report 59/F India Enlarging neck mass with hoarseness of voice, dry cough, and increasing neck pain 5 years None N/A N/A None Thyroid gland FNA US: 3 nodules (left lobe, mid/inferior pole, isthmus) with calcification and cystic areas; CT: heterogeneous left thyroid mass displacing strap muscles and vessels, multiple enlarged cervical nodes. De Giorgi et al., 2005 [31] Case report 38/F Italy Pigmented lesion on the hip 6 months Cutaneous malignant melanoma Previous melanoma excision N/A N/A Hip skin Clinical exam, dermoscopy, surgical excision Dermoscopy: pigment network, regressive white area, punctiform vessels, blue-grey globules, pseudohorn cysts. Badiali et al., 1987 [32] Case report 63/M Italy Shortness of breath; occasional hemoptysis 1 month Chronic bronchitis and emphysema; 48-year smoking history None N/A None Lung Cytologic sputum exam, bronchoscopy Chest X-ray: large lobulated upper lobe mass (6 cm), smaller peripheral lower lobe lesion (3 cm); CT: confirmed lesions; bone/liver scans negative. CT: Computed tomography; FDG: Fluorodeoxyglucose; F: Female; FNA: Fine needle aspiration; GERD: Gastroesophageal reflux disease; GI: Gastrointestinal; IHC: Immunohistochemistry; M: Male; MAG3: Mercaptoacetyltriglycine; MRI: Magnetic resonance imaging; N/A: Not applicable; NMSC: Non-melanoma skin cancers; PET-CT: Positron emission tomography–computed tomography; SCC: Squamous cell carcinoma; SUV: Standardized Uptake Value; US: Ultrasonography; UTIs: Urinary tract infections; XGP: Xanthogranulomatous Pyelonephritis; yr: Year; DVT: Deep vein thrombosis. Demographic and Clinical Characteristics The mean age at diagnosis was 63.46 ± 14.00 years. Of the 28 patients, 17 female cases (60.71%) and 11 male cases (39.29%) were identified. The most commonly affected organs were the thyroid, with 7 cases (25.0%), and the skin, with 5 cases (17.86%). The esophagus, kidney, lung, and uterus were each involved in 3 cases (10.71%). Clinical manifestations varied according to tumor location. In thyroid tumors, thyroid nodules were the most common presenting symptom, observed in 3 cases (42.86%). Among skin tumors, lesions were reported in 3 cases (60.0%). All esophageal tumors presented with dysphagia (Table 1). Diagnostic Modalities and Interventions The most frequently used initial diagnostic method was biopsy, performed in 21 cases (75.0%), followed by CT scan in 9 cases (32.14%) and ultrasound in 7 cases (25.0%) (Table 1). Surgical intervention was performed in 26 cases (92.86%), tailored to tumor type and location (Table 2). Among all cases, 15 cases (53.57%) received adjuvant therapy, most commonly radiotherapy in 9 cases (60.0%), followed by chemotherapy in 5 cases (33.33%) (Table 3). Table 2. Surgical Management and Histopathological Characterization of Reported Complex Collision Tumors Author (yr) Type of surgery performed Collision tumor Short HPE description 1st tumor 2nd tumor 3rd tumor 4th tumor 1st tumor 2nd tumor 3rd tumor 4th tumor Luo et al., 2024 [5] Thoracoscopic-laparoscopic partial esophagectomy with lymphadenectomy Undifferentiated pleomorphic sarcoma Adenoid cystic carcinoma Squamous cell carcinoma None Storiform pattern, pleomorphic cells, myxoid degeneration. IHC: Vimentin+, CD68+, Desmin focal+, CD56+ Cribriform/tubular/solid patterns, glandular and myoepithelial cells. IHC: CK5/6+, p63+, CD117+, EMA+, S100 weak focal+, SMA weak focal+ Confined to mucosa, incomplete keratinization, and intercellular bridges. IHC: CK+, CK5/6+, EMA+, P40+, p63+, BerEP4 focal+ N/A Bahbahani et al., 2023 [9] Radical left nephrectomy Multilocular cystic clear cell renal cell carcinoma Clear cell papillary renal cell carcinoma Renal oncocytoma Renomedullary interstitial cell tumor Multilocular cystic tumor with thin fibrous septa and serous to gelatinous fluid. IHC: Not reported Solid, hemorrhagic, cystic tumor in the medulla. IHC: Not reported Well-demarcated, unencapsulated brown-tan nodule in cortex with pushing border. IHC: Not reported Composed of stellate cells in loose fibrotic basophilic stroma with entrapped tubules. IHC: Not reported Boukhannous et al., 2022 [10] Radical right nephrectomy Papillary Renal Cell Carcinoma Chromophobe Renal Cell Carcinoma Sarcomatoid dedifferentiation None Papillae of carcinomatous cells, moderate to marked nucleocytoplasmic atypia. IHC: CD10+, CK7+, vimentin+, pancytokeratin (weak +) Large nests of cells with abundant cytoplasm and perinuclear halo. IHC: CK7+, CD117+, E-cadherin+ Sheets of atypical spindle/giant cells, high mitotic activity. IHC: Not reported. N/A Rose et al., 2021 [11] Wedge excision, followed by re-excision Squamous cell carcinoma Basal cell carcinoma Invasive nodular melanoma None Moderately differentiated (pT2). IHC: Not reported Infiltrative (pT1). IHC: Not reported Invasive nodular (pT3a), 2.8 mm Breslow thickness. IHC: Melan-A+; others not specified N/A Rupchandani et al., 2021 [12] Excisional biopsy Merkel cell carcinoma Sebaceous carcinoma Bowen’s disease (Squamous cell carcinoma in situ) None Dermal nodules of small, round, blue cells. IHC: Not reported Lobular architecture with sebaceous differentiation. IHC: Not reported Full-thickness epidermal atypia (SCC in situ). IHC: Not reported N/A Toyoshima et al., 2021 [13] Total thyroidectomy; later bilateral neck dissection Widely invasive oncocytic carcinoma Classical variant papillary thyroid carcinoma Hobnail variant of PTC Poorly differentiated thyroid carcinoma Capsular invasion, oncocytic cells. IHC:Thyroglobulin+, TTF-1+, PAX8 focal+, p53+ Classical papillary architecture. IHC: Thyroglobulin+, TTF-1 inconclusive, p53 inconclusive Hobnail features with nuclear atypia and eosinophilic cytoplasm. IHC: Thyroglobulin+, p53+ Solid blocks with atypia, mitoses, and necrosis. IHC: Thyroglobulin+, p53+; Metastases: CK7+, GATA3+, negative for PAX8, TTF-1 Hobbs et al., 2020 [14] Mohs micrographic surgery followed by WLE and sentinel lymph node biopsy Merkel cell carcinoma Squamous cell carcinoma in situ Basal cell carcinoma None Small blue cell tumor, neuroendocrine features, stippled chromatin, molding, high mitotic activity. IHC: TTF-1+, CK20−, synaptophysin+, CAM5.2+, AE1/AE3 (dot-like), neurofilament (rare +), chromogranin− Intraepidermal atypia. IHC: CK5/6+ Peripheral palisading, retraction artifact. IHC: BerEP4+, chromogranin+, synaptophysin+, CK7 (some areas) N/A Lai et al., 2020 [15] Robotic minimally invasive esophagectomy, gastric tube reconstruction, cervical esophagogastrostomy, feeding jejunostomy Small cell carcinoma Squamous cell carcinoma Adenocarcinoma None Major component, poorly differentiated (G3), positive for insulinoma-associated one and CD56. IHC: insulinoma-associated 1+, CD56+, p40− IHC: p40+ Morphology consistent with glandular origin. IHC: Not reported N/A Mizoguchi et al., 2020 [16] Total abdominal hysterectomy with bilateral salpingo-oophorectomy Low-grade endometrial stromal sarcoma Uterine tumor resembling ovarian sex-cord tumor Leiomyoma None CD10+, sex cord-like differentiation, necrosis, MI 20/10 HPF. IHC: CD10+ CD10−, cords of epithelioid/spindle cells, hyalinized stroma. IHC: CD10−; cyclin D1 negative Spindle cells in fascicles, infarct-type necrosis. IHC: Not reported N/A Roshini et al., 2018 [17] Right hemithyroidectomy followed by completion thyroidectomy Not otherwise specified follicular-pattern carcinoma Papillary thyroid carcinoma Medullary thyroid carcinoma None Well-differentiated follicular pattern, capsular invasion. IHC: Not reported Classical nuclear features in Hashimoto’s background. IHC: Not reported Oval-to-spindle cells with salt and pepper chromatin. IHC: Synaptophysin (3+, 90%), CEA (3+, 90%), Chromogranin (2+, 90%) N/A Liu et al., 2017 [18] Laparoscopic right adrenalectomy Adrenal adenoma Myelolipoma Metastatic breast carcinoma None Zona fasciculata-like cells. IHC: Inhibin+, GATA-3− 4 mm focus within adenoma. IHC: Not reported Scattered atypical cells (~2% mass). IHC: GATA-3+, CK7+, ER+, PR+, CKAE1/AE3+, inhibin− N/A Schizas et al., 2017 [19] Transthoracic total esophagectomy with standard lymphadenectomy Small cell carcinoma (neuroendocrine) Moderately differentiated adenocarcinoma Signet ring cell carcinoma None Neuroendocrine appearance, upper lesion. IHC: Not reported Moderately differentiated, enteric type. IHC: Not reported Signet ring cell carcinoma: poorly cohesive adenocarcinoma, lower lesion. IHC: Not reported N/A Masuyama et al., 2016 [20] Radical hysterectomy, bilateral adnexectomy, pelvic lymph node dissection Endometrioid carcinoma Undifferentiated carcinoma Choriocarcinoma None G2, squamous differentiation, confined to the endometrium. IHC: Not reported Invaded half of the myometrium. IHC: Not reported Lymphovascular invasion, no endometrioid component. IHC: Not reported N/A Bloom et al., 2014 [21] Shave biopsy Eccrine poroma Seborrheic keratosis Viral wart None Bulbous aggregates of small squamous cells with eccrine ductal differentiation. IHC: Not reported Horn pseudocysts, hypergranulosis, compact orthokeratosis with parakeratosis. IHC: Not reported Papillated and polypoid lesion with crusting, spongiosis, and inflammatory infiltrate (neutrophils, plasma cells, lymphocytes). IHC: Not reported N/A Kim et al., 2014 [22] Bilateral total thyroidectomy with central neck dissection Follicular carcinoma Papillary microcarcinoma Medullary carcinoma None 4.3 cm with capsular invasion. IHC: Not reported 0.3 cm microcarcinoma, papillary features. IHC: Not reported 0.8 cm, small round nuclei, positive calcitonin staining. IHC: calcitonin+ N/A Suzuki et al., 2014 [23] Right lower lobectomy with mediastinal lymph node dissection Invasive mucinous adenocarcinoma Invasive non-mucinous adenocarcinoma Squamous cell carcinoma None Columnar, mucin-secreting cells with papillary invasion. IHC: Not reported Invasive glandular growth. IHC: Not reported Pseudostratified cells with keratinization and angular nuclei. IHC: Not reported N/A Adnan et al., 2013 [24] Total thyroidectomy + right modified neck dissection Medullary thyroid carcinoma Papillary thyroid microcarcinoma Follicular thyroid adenoma None Nests of oval cells. IHC: calcitonin+, thyroglobulin− IHC: thyroglobulin+ microfollicular pattern. IHC: Not reported N/A Total thyroidectomy + right modified neck dissection Medullary thyroid carcinoma Papillary thyroid microcarcinoma Follicular thyroid adenoma None IHC: calcitonin+, chromogranin+, synaptophysin+, CEA (partial)+ Not reported Not reported N/A Right thyroidectomy and isthmectomy Medullary thyroid carcinoma Papillary thyroid microcarcinoma Follicular thyroid adenoma None IHC: calcitonin+, CEA+, pankeratin+ Not reported Not reported N/A Cornejo et al., 2013 [25] WLE Melanoma Squamous cell carcinoma Basal cell carcinoma None High-grade atypia, pleomorphism, hyperchromasia, multinucleation, prominent nucleoli, brisk mitotic activity, involved hair follicles. IHC: S-100+, MART-1+, HMB-45+ Eosinophilic cytoplasm, marked nuclear atypia. IHC: cytokeratins+, p63+ but negative for Ber-EP4 and CD10 Basaloid cells with peripheral palisading. IHC: cytokeratins+, Ber-EP4+, CD10+ N/A Jang et al., 2012 [1] Total hysterectomy, bilateral salpingo-oophorectomy, lymphadenectomy, omentectomy, appendectomy Malignant mixed müllerian tumor Papillary serous carcinoma Endometrioid adenocarcinoma None Carcinomatous (glandular) and sarcomatous (spindle cell) components. IHC: p53+, CK+ (carcinoma), vimentin+ (sarcoma), MyoD1 focal+ Papillary growth, poorly differentiated, myometrial invasion. IHC: p53+, CK+, PR+, ER- Glandular and solid patterns with squamous differentiation, confined to endometrium. IHC: p53+, CK+, ER-, PR- N/A Rothschild et al., 2010 [26] Radical left nephrectomy Squamous cell carcinoma Osteogenic sarcoma Xanthogranulomatous pyelonephritis None Moderately differentiated, keratinizing, with necrosis and angiolymphatic invasion. IHC: Not reported High-grade spindle/polyhedral cells producing unmineralized osteoid. IHC: CD10+, pancytokeratin–, EMA–, SMA–, S100–, ALK-1– Lipid-laden macrophages, foamy histiocytes, and abscess formation. IHC: Not reported N/A Terada, 2010 [27] None; treated with chemotherapy only; autopsy performed after death Adenocarcinoma Squamous cell carcinoma Small cell carcinoma None Irregular glands with atypical cells and desmoplastic stroma. IHC: CK7+, CK8+, CK18+, CK19+, EMA+, CEA+, PDGFRA+ Keratinizing nests with intercellular bridges; merged with adenocarcinoma. IHC: CK5/6+, CK7+, CK8+, EMA+, CEA+, PDGFRA+ Small hyperchromatic cells with nuclear molding; distinct and separate. IHC: CK18+, chromogranin+, synaptophysin+, CD56+, PDGFRA+ N/A Broughton et al., 2008 [28] Left upper-inner quadrantectomy and axillary lymph node dissection Infiltrating lobular carcinoma (from breast cancer) Scleronodular Hodgkin’s disease Tuberculous lymphadenitis None Cohesive sheets of tumor cells (metastasis in the lymph node). IHC: ER+, Cerb2 (HER2) - Reed-Sternberg cells in hyperplastic cortex/para-cortex. IHC: Not reported Caseous necrosis, granulomas with epithelioid and Langhans giant cells. IHC: Not reported N/A Wang et al., 2008 [29] Biopsy only Mantle cell lymphoma (IgM+ phenotype) Mantle cell lymphoma (IgA+ phenotype) Extramedullary plasmacytoma None Sheets of small- to medium-sized lymphoid cells with slightly irregular nuclear contours and scant cytoplasm. IHC: CD20+, CD5+, cyclin D1+, IgM+ Similar morphology to the IgM+ MCL, but a distinct population based on immunophenotyping. IHC: CD20+, CD5+, cyclin D1+, IgA+ Composed of mature-appearing plasma cells arranged in sheets. IHC: CD138+, CD20−, IgG+, κ+, λ−, cyclin D1− N/A Rekhi et al., 2007 [30] Total thyroidectomy with bilateral cervical lymph node dissection Medullary thyroid carcinoma Papillary thyroid carcinoma Follicular variant of Papillary thyroid carcinoma None Nests of plasmacytoid cells with amyloid stroma. IHC: Calcitonin+, CEA+, Chromogranin+ Clear nuclei, grooves, and intranuclear inclusions. IHC: Thyroglobulin+ Papillary structures with colloid-filled cystic areas. IHC: Thyroglobulin+ N/A De Giorgi et al., 2005 [31] Surgical excision Melanocytic compound naevus Nodular basal cell carcinoma Seborrhoeic keratosis None Nests of pigmented melanocytes without significant atypia. IHC: Not reported Basaloid cells with peripheral palisading, clefts between the tumor and stroma. IHC: Not reported Pigmented basaloid cell proliferation, small keratin-filled cysts. IHC: Not reported N/A Badiali et al., 1987 [32] Right upper lobectomy, atypical resection of RLL, total right pneumonectomy Squamous cell carcinoma Small cell carcinoma Adenocarcinoma None Moderately differentiated; keratinization; intercellular bridges. IHC: Not reported Typical intermediate type; high nuclear-cytoplasmic ratio. IHC: Grimelius stain + Well-differentiated, mucin-secreting cells; glandular formation. IHC: Not reported N/A IHC: Immunohistochemistry; N/A: Not applicable; WLE: Wide local excision; yr: Year; HPE: Histopathological examination; SCC: Squamous cell carcinoma; PTC: Papillary thyroid carcinoma; MCL: Mantle cell lymphoma; RLL: Right lower lobe Table 3. Clinical outcomes and follow-up data Author (yr) Lymph node metastasis Organ metastasis Adjuvant therapies Postoperative complications Follow-up duration Recurrence Status at last follow-up Luo et al., 2024 [5] Yes, the middle esophageal lymph node N/A None N/A 101 months None Alive, no recurrence or metastasis Bahbahani et al., 2023 [9] None None None Elevated creatinine/eGFR drop 1 week None Alive with stable disease Boukhannous et al., 2022 [10] Yes, ipsilateral hilar lymphadenopathy Lungs Sunitinib N/A 1 year None Alive with stable disease Rose et al., 2021 [11] N/A N/A None N/A Ongoing at the time of the report N/A Alive, on regular follow-up Rupchandani et al., 2021 [12] Yes, extensive nodal disease in the right axilla and subpectoral region None Palliative radiotherapy N/A 43 days Local recurrence at the distal forearm wound site before radiotherapy Deceased Toyoshima et al., 2021 [13] Yes, bilateral cervical levels II–V, extracapsular invasion Lungs and liver RAI therapy (206 mCi); external-beam radiotherapy; sorafenib Developed respiratory failure; tracheostomy required 12 months Local, lymph node, and distant (lung and liver) Deceased Hobbs et al., 2020 [14] Yes, positive sentinel lymph node biopsy None N/A N/A N/A N/A Alive, under evaluation. Lai et al., 2020 [15] Yes, pericardial lymph nodes Esophagus Concurrent chemoradiation therapy with etoposide and cisplatin N/A N/A N/A Alive, under treatment Mizoguchi et al., 2020 [16] None None None N/A 6 months None Alive and disease-free Roshini et al., 2018 [17] N/A N/A N/A N/A N/A N/A Alive, on regular follow-up Liu et al., 2017 [18] Yes, axillary lymph nodes Adrenal gland, bone, left supraclavicular region, lung hila Aromatase inhibitor N/A 10 months Progression of metastatic disease Deceased Schizas et al., 2017 [19] Yes, the Gastrohepatic ligament lymph node Liver Cisplatin and etoposide N/A 6 months Multiple liver metastases Alive, undergoing definitive chemotherapy Masuyama et al., 2016 [20] Yes, the left external iliac lymph node None 6 cycles paclitaxel/carboplatin + 5 cycles methotrexate N/A 1 year N/A Alive and disease-free Bloom et al., 2014 [21] None None None N/A N/A N/A N/A Kim et al., 2014 [22] None None RAI (130 mCi) N/A 7 months None Alive and disease-free Suzuki et al., 2014 [23] None N/A None N/A 12 months N/A Alive and disease-free Adnan et al., 2013 [24] None None RAI (I-131, 100 mCi) N/A 1 year None Alive and disease-free None None RAI (I-131, 100 mCi) N/A N/A None Alive and disease-free None None None N/A N/A None Alive and disease-free Cornejo et al., 2013 [25] N/A N/A None N/A 6 months None Alive and disease-free Jang et al., 2012 [1] Yes, pelvic and para-aortic lymph nodes Omentum, serosa of the sigmoid colon Intraperitoneal chemotherapy (paclitaxel); systemic chemotherapy (paclitaxel, epirubicin, carboplatin); radiation therapy N/A 8 years None Alive and disease-free Rothschild et al., 2010 [26] None N/A N/A N/A N/A N/A Alive Terada, 2010 [27] Yes, systemic lymph nodes are positive for all three components Lungs, pleura, brain, bones, liver Chemotherapy N/A 7 months (from diagnosis to death) N/A Deceased Broughton et al., 2008 [28] Yes, nodes positive for breast carcinoma N/A Tamoxifen (for breast cancer), six cycles ABVD chemotherapy (for Hodgkin’s), 9-month anti-TB (isoniazid, rifampicin, ethambutol) Progressive anemia N/A N/A Alive with stable disease Wang et al., 2008 [29] N/A Bone marrow Radiotherapy to the nasopharynx (50 Gy in 25 fractions) N/A 15 months None Alive Rekhi et al., 2007 [30] Yes N/A RAI ablation (195 mCi) N/A Ongoing at the time of the report N/A Alive, on regular follow-up De Giorgi et al., 2005 [31] None None None N/A N/A N/A Alive and disease-free Badiali et al., 1987 [32] None None None Empyema

Zitieren

APA

Abuquteish, D., & Al-Qudah, M. A. (2025). Complex Collision Tumors: A Systematic Review. Judi Clinical Journal. https://doi.org/10.70955/jcj.2025.13

Vancouver

Abuquteish D, Al-Qudah MA. Complex Collision Tumors: A Systematic Review. Judi Clinical Journal. 2025. doi:10.70955/jcj.2025.13

BibTeX
@article{Abuquteish2025,
  author = {Abuquteish, Dua and Al-Qudah, Mohammad A.},
  title = {Complex Collision Tumors: A Systematic Review},
  journal = {Judi Clinical Journal},
  year = {2025},
  doi = {10.70955/jcj.2025.13}
}
Kostenlos starten →